A troubling jaw disease that may be related to the use of some of the most commonly used osteoporosis medications has been the subject of many news stories and law firm commercials lately. The disease ...

Please provide your email address to receive an email when new articles are posted on . “Although we observed an increasing number of osteonecrosis of the jaw cases in our daily practice during the ...

Philadelphia, PA - A review of jaw osteonecrosis as a recently described adverse effect of bisphosphonate therapy in the May 16, 2006 issue of the Annals of Internal Medicine concludes that most cases ...

Taking bisphosphonates for osteoporosis can be like rain on your wedding day. Although bisphosphonate drugs are great at battling osteoporosis, they can also cause the rare, but serious condition of ...

The use of antiresorptive drugs for tumor-related disorders and oral, but not injectable, corticosteroids were associated with an increased risk for osteonecrosis of the jaw among patients with ...

Phase I/II Trial Assessing Bortezomib and Melphalan Combination Therapy for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma A retrospective review of 90 MM patients who had ...

Osteonecrosis of the jaw (ONJ) is a serious complication for physicians prescribing bone resorption inhibitors to patients with osteoporosis. A session at the recent French Congress of Rheumatology ...

Cancer patients undergoing bone-saving therapy show tendency toward osteonecrosis. BOSTON—IV bisphosphonates may increase the risk of osteonecrosis of the jaw (ONJ), according to new findings.

Survivors of COVID-19 may be at risk of developing spontaneous osteonecrosis of the jaw, according to a case series published June 14 in BMC Infectious Diseases. These are believed to be the first ...

Survival outcomes based on line of therapy and treatment trends with cabazitaxel in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC). Term Induction phase Arm A (q4w) Arm B ...